Brian Helfand

Mar 26, 2024 | urologytimes.com | Matthew Smith |Brian Helfand

Two prostate cancer experts discuss treatment decision-making practices for patients with newly diagnosed metastatic disease.

Mar 19, 2024 | urologytimes.com | Matthew Smith |Brian Helfand

A comprehensive discussion on diagnostic practices in prostate cancer, highlighting imaging practices and the differences between castration-resistant prostate cancer and hormone-sensitive prostate cancer.

Mar 19, 2024 | urologytimes.com | Matthew Smith |Brian Helfand

Matthew Smith, MD, PhD, and Brian T. Helfand, MD, introduce themselves and provide clinical insights on screening practices for patients with prostate cancer.

Mar 18, 2024 | urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins

Future Horizons in PSMA-Targeted Imaging and the Management of Prostate CancerExperts close their discussion by highlighting the future landscape of PSMA-targeted imaging in the management of prostate cancer.

Mar 11, 2024 | urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins

Drs Helfand, Chapin, and Collins, review the case of 67-year-old man treated with recurring prostate cancer.